# Meningococcal Serogroup ACYWX Conjugate Vaccine in Comparison With MenACWY-TT Conjugate Vaccine

> **NCT05093829** · PHASE3 · COMPLETED · sponsor: **Emory University** · enrollment: 1325 (actual)

## Conditions studied

- Meningitis

## Interventions

- **BIOLOGICAL:** NmCV-5
- **BIOLOGICAL:** MenACWY-TT

## Key facts

- **NCT ID:** NCT05093829
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-24
- **Primary completion:** 2023-03-10
- **Final completion:** 2025-02-20
- **Target enrollment:** 1325 (ACTUAL)
- **Last updated:** 2026-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05093829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05093829, "Meningococcal Serogroup ACYWX Conjugate Vaccine in Comparison With MenACWY-TT Conjugate Vaccine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05093829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*